Impact of drug tolerability on the selection of antidepressant treatment in patients with major depressive disorder
- PMID: 20397586
- DOI: 10.1017/s1092852900026353
Impact of drug tolerability on the selection of antidepressant treatment in patients with major depressive disorder
Abstract
Despite significant progress in the development of antidepressant therapies, tolerability remains an important factor associated with the selection of appropriate antidepressant treatment. Side effects commonly reported by depressed patients taking antidepressants include weight gain, sexual dysfunction, and gastrointestinal effects.Tolerability issues associated with antidepressants can negatively impact treatment outcomes for patients with major depressive disorder. In addition, a drug's tolerability profile substantially influences a physician's choice of specific antidepressant therapy, Despite the availability of many antidepressants, empirical clinical evidence to guide physicians in making the best choice is limited and not always clear.Thus, it is key for clinicians to understand the short- and long-term outcomes and side effect profiles of the available antidepressants.
Similar articles
-
Factors impacting the selection of antidepressant treatment in patients with major depressive disorder at risk for nonadherence.CNS Spectr. 2009 Dec;14(12 Suppl 12):15-9. doi: 10.1017/s1092852900026365. CNS Spectr. 2009. PMID: 20397587 Review.
-
Limitations of contemporary antidepressants: tolerability.J Clin Psychiatry. 2007;68 Suppl 10:11-7. J Clin Psychiatry. 2007. PMID: 17900204
-
Augmentation strategies to increase antidepressant tolerability.J Clin Psychiatry. 2007;68 Suppl 10:23-7. J Clin Psychiatry. 2007. PMID: 17900206 Review.
-
Why isn't bupropion the most frequently prescribed antidepressant?J Clin Psychiatry. 2005 May;66(5):603-10. doi: 10.4088/jcp.v66n0510. J Clin Psychiatry. 2005. PMID: 15889947 Review.
-
Sexual dysfunction associated with major depressive disorder and antidepressant treatment.Expert Opin Drug Saf. 2014 Oct;13(10):1361-74. doi: 10.1517/14740338.2014.951324. Epub 2014 Aug 22. Expert Opin Drug Saf. 2014. PMID: 25148932 Review.
Cited by
-
Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.Int Clin Psychopharmacol. 2014 Jan;29(1):36-44. doi: 10.1097/YIC.0000000000000010. Int Clin Psychopharmacol. 2014. PMID: 24169027 Free PMC article. Clinical Trial.
-
Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine.Neuropsychopharmacology. 2015 Mar;40(4):938-46. doi: 10.1038/npp.2014.269. Epub 2014 Oct 7. Neuropsychopharmacology. 2015. PMID: 25288485 Free PMC article.
-
α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties.Behav Pharmacol. 2011 Aug;22(4):291-9. doi: 10.1097/FBP.0b013e328347546d. Behav Pharmacol. 2011. PMID: 21566524 Free PMC article.
-
Pharmacokinetics, Safety, and Tolerability of Vortioxetine Following Single- and Multiple-Dose Administration in Healthy Japanese Adults.Clin Pharmacol Drug Dev. 2018 Mar;7(3):319-331. doi: 10.1002/cpdd.381. Epub 2017 Sep 21. Clin Pharmacol Drug Dev. 2018. PMID: 28941196 Free PMC article. Clinical Trial.
-
Clinical preference for factors in treatment of geriatric depression.Neuropsychiatr Dis Treat. 2014 Dec 22;11:25-31. doi: 10.2147/NDT.S75450. eCollection 2015. Neuropsychiatr Dis Treat. 2014. PMID: 25565848 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical